Vaccination against meningococcus in complement-deficient individuals.
作者信息
Morgan B P, Orren A
机构信息
Complement Biology Group, Department of Medical Biochemistry, UWCM, Cardiff, UK.
出版信息
Clin Exp Immunol. 1998 Dec;114(3):327-9. doi: 10.1046/j.1365-2249.1998.00734.x.
Abstract
摘要
相似文献
1
Vaccination against meningococcus in complement-deficient individuals.补体缺陷个体的脑膜炎球菌疫苗接种。
Clin Exp Immunol. 1998 Dec;114(3):327-9. doi: 10.1046/j.1365-2249.1998.00734.x.
2
Meningococcal vaccines.脑膜炎球菌疫苗
J Med Microbiol. 1988 Jul;26(3):170-2.
3
Protection against meningococcal serogroup ACYW disease in complement-deficient individuals vaccinated with the tetravalent meningococcal capsular polysaccharide vaccine.在接种四价脑膜炎球菌结合疫苗的补体缺陷个体中预防A、C、Y和W135群脑膜炎球菌疾病
Clin Exp Immunol. 1998 Dec;114(3):362-9. doi: 10.1046/j.1365-2249.1998.00738.x.
4
The role of complement in anti-bacterial defence.补体在抗菌防御中的作用。
Ann Ital Med Int. 1994 Jul-Sep;9(3):173-7.
5
The last of the meningococcus?脑膜炎球菌的末日？
Adv Exp Med Biol. 2004;549:201-9. doi: 10.1007/978-1-4419-8993-2_27.
6
[Immunoprophylaxis of meningococcal infection among the troops].[部队中脑膜炎球菌感染的免疫预防]
Voen Med Zh. 1984 Oct(10):51-3.
7
Can meningococcal C conjugate vaccine overcome immune hyporesponsiveness induced by previous administration of plain polysaccharide vaccine?脑膜炎球菌C结合疫苗能否克服先前接种普通多糖疫苗引起的免疫低反应性？
JAMA. 2000 Apr 12;283(14):1826-7. doi: 10.1001/jama.283.14.1826.
8
Meningococcal Serogroup A, B, C, W, X, and Y Serum Bactericidal Antibody Assays.A、B、C、W、X和Y群脑膜炎球菌血清杀菌抗体检测
Methods Mol Biol. 2019;1969:169-179. doi: 10.1007/978-1-4939-9202-7_12.
9
10
Phagocytic killing and antibody response during the first year after tetravalent meningococcal vaccine in complement-deficient and in normal individuals.四价脑膜炎球菌疫苗接种后第一年，补体缺陷个体与正常个体的吞噬细胞杀伤作用及抗体反应。
J Clin Immunol. 2000 Jan;20(1):46-53. doi: 10.1023/a:1006642611069.
引用本文的文献
1
Recurrent meningococcal meningitis with complement 6 (C6) deficiency: A case report.复发性脑膜炎球菌性脑膜炎伴补体6（C6）缺乏：一例报告。
Medicine (Baltimore). 2020 May 22;99(21):e20362. doi: 10.1097/MD.0000000000020362.
2
Antibody-mediated complement activation in pathology and protection.抗体介导的补体激活在病理学和保护中的作用。
Immunol Cell Biol. 2020 Apr;98(4):305-317. doi: 10.1111/imcb.12324. Epub 2020 Apr 6.
3
Exome sequencing in routine diagnostics: a generic test for 254 patients with primary immunodeficiencies.外显子组测序在常规诊断中的应用：对 254 例原发性免疫缺陷患者的通用检测。
Genome Med. 2019 Jun 17;11(1):38. doi: 10.1186/s13073-019-0649-3.
4
Modern complement analysis.现代补体分析
Clin Diagn Lab Immunol. 2003 Nov;10(6):982-9. doi: 10.1128/cdli.10.6.982-989.2003.
5
A glycoconjugate vaccine for Neisseria meningitidis induces antibodies in human infants that afford protection against meningococcal bacteremia in a neonate rat challenge model.一种针对脑膜炎奈瑟菌的糖缀合物疫苗可在人类婴儿中诱导产生抗体，这些抗体在新生大鼠攻毒模型中能提供针对脑膜炎球菌血症的保护作用。
Infect Immun. 2002 Dec;70(12):6576-82. doi: 10.1128/IAI.70.12.6576-6582.2002.
6
Development of antibodies against tetravalent meningococcal polysaccharides in revaccinated complement-deficient patients.再次接种疫苗的补体缺陷患者中针对四价脑膜炎球菌多糖抗体的产生情况。
Clin Exp Immunol. 2000 Feb;119(2):311-6. doi: 10.1046/j.1365-2249.2000.01130.x.
7
Molecular mechanisms of complement component C6 deficiency; a hypervariable exon 6 region responsible for three of six reported defects.补体成分C6缺乏的分子机制；一个高度可变的外显子6区域导致了所报道的六个缺陷中的三个。
Clin Exp Immunol. 2000 Feb;119(2):255-8. doi: 10.1046/j.1365-2249.2000.01141.x.
8
Properdin deficiency and meningococcal disease--identifying those most at risk.备解素缺乏与脑膜炎球菌病——识别高危人群。
Clin Exp Immunol. 1999 Nov;118(2):189-91. doi: 10.1046/j.1365-2249.1999.01057.x.
本文引用的文献
1
Protection against meningococcal serogroup ACYW disease in complement-deficient individuals vaccinated with the tetravalent meningococcal capsular polysaccharide vaccine.在接种四价脑膜炎球菌结合疫苗的补体缺陷个体中预防A、C、Y和W135群脑膜炎球菌疾病
Clin Exp Immunol. 1998 Dec;114(3):362-9. doi: 10.1046/j.1365-2249.1998.00738.x.
2
Efficacy of meningococcal vaccine and barriers to vaccination.脑膜炎球菌疫苗的功效及疫苗接种的障碍。
JAMA. 1998 Feb 11;279(6):435-9. doi: 10.1001/jama.279.6.435.
3
How do mammals distinguish between pathogens and non-self?哺乳动物如何区分病原体和非自身物质？
Trends Microbiol. 1996 Jul;4(7):254-7. doi: 10.1016/0966-842x(96)30019-x.
4
C3d of complement as a molecular adjuvant: bridging innate and acquired immunity.补体C3d作为分子佐剂：连接固有免疫和获得性免疫
Science. 1996 Jan 19;271(5247):348-50. doi: 10.1126/science.271.5247.348.
5
Recurrent meningococcal septicaemia and properdin deficiency.复发性脑膜炎球菌败血症与备解素缺乏症
J Infect. 1995 Jul;31(1):67-8. doi: 10.1016/s0163-4453(95)91550-8.
6
Vaccination and the role of capsular polysaccharide antibody in prevention of recurrent meningococcal disease in late complement component-deficient individuals.疫苗接种及荚膜多糖抗体在预防晚期补体成分缺陷个体复发性脑膜炎球菌病中的作用。
J Infect Dis. 1993 Jul;168(1):227-31. doi: 10.1093/infdis/168.1.227.
7
Dramatic reduction of meningococcal meningitis among military recruits in Italy after introduction of specific vaccination.在意大利引入特定疫苗接种后，新兵中脑膜炎球菌性脑膜炎的发病率大幅下降。
Vaccine. 1993;11(5):578-81. doi: 10.1016/0264-410x(93)90236-q.
8
Antibody response to meningococcal polysaccharides A and C in patients with complement defects.补体缺陷患者对A群和C群脑膜炎球菌多糖的抗体反应。
Scand J Immunol. 1993 Jun;37(6):644-50. doi: 10.1111/j.1365-3083.1993.tb01677.x.
9
Meningococcal disease in patients with late complement component deficiency: studies in the U.S.S.R.晚期补体成分缺乏患者的脑膜炎球菌病：苏联的研究
Medicine (Baltimore). 1993 Nov;72(6):374-92. doi: 10.1097/00005792-199311000-00002.
10
Killing of meningococci by neutrophils: effect of vaccination on patients with complement deficiency.中性粒细胞对脑膜炎球菌的杀伤作用：疫苗接种对补体缺陷患者的影响。
J Infect Dis. 1994 Aug;170(2):449-53. doi: 10.1093/infdis/170.2.449.
Zotero 插件